VISTIN PHARMA ASA: årsregnskap 2016 vs 2015
Grew 73% on revenue, fresh owner capital
approved 2017-04-25; registry 2017-06-24; journal 2017 501517
Summary
What changed
Comparing Årsregnskap 2016 with 2015 for VISTIN PHARMA ASA. Revenue 227.9k NOK → 394.8k NOK (+73.2%). Equity 170.52m NOK → 163.61m NOK.
On the constructive side: revenue rose; cash rose; owners injected capital. Pressures included: equity eroded.
Also worth watching: cogs moved; book investments changed. All figures are taken from the published annual accounts for VISTIN PHARMA ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 227.9k NOK to 394.8k NOK (+73.2% YoY). Calculated
-
↑
Cash rose
Bank deposits 22 NOK → 20.20m NOK (+91831718.2% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 170.5k NOK → 163.61m NOK (+163.44m NOK). Reported fact
What deteriorated
-
↓
Equity eroded
Book equity 170.52m NOK → 163.61m NOK (equity ratio 99.6% → 98.8%). Calculated
Things to notice
-
·
COGS moved
COGS / varekostnad 17 NOK → 15.16bn NOK (+89195282252.9% YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 145.5k NOK → 145.47m NOK. Reported fact